The [64Cu]Cu-DO3A-VS-M5A∆CH2-C5 PET imaging demonstrated high tumor targeting and favorable pharmacokinetics in two CEA-positive colorectal cancer mouse models. This evidence concerns the gene CEACAM5 and neoplasm.